Recent Trends in Investigational Drug Application (IND) in Asia Pacific Countries

In recent years, it becomes a trend that multinational companies move the drug development to Asia Pacific countries and conduct clinical trials there. It necessitates the needs of familiarizing with the ever changing regulatory environment of the region. This presentation will provide an overview of the complex regulatory landscape in the Asia Pacific region with the focus on specific requirements, challenges and trends for Investigational Drug Application (IND)/Clinical Trial Application (CTA). Participants will have an understanding of detailed country-specific CMC requirements for IND/CTA, challenges and potential opportunities in supporting of IND/CTA, and recent updates and trends related to IND/CTA.